Header Logo

Connection

JASON ROBERT WESTIN to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications JASON ROBERT WESTIN has written about Antibodies, Bispecific.
JASON ROBERT WESTIN
Connection Strength
0.654
Antibodies, Bispecific
  1. Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphoma. Leuk Lymphoma. 2022 09; 63(9):2041-2051.
    View in: PubMed
    Score: 0.654
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.